Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide

Journal of Medicinal Chemistry

Volumn 40, Issue 22, 1997, Pages 3626-3634

  Seltzman, Herbert H ^a   Fleming, Denise N ^a   Thomas, Brian F ^a   Gilliam, Anne F ^a   McCallion, Deirdre S ^b   Pertwee, Roger G ^b   Compton, David R ^c   Martin, Billy R ^c  

^a RTI INTERNATIONAL   (United States)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE;

ARACHIDONIC ACID METABOLISM; ARTICLE; BINDING SITE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG SYNTHESIS; LIGAND BINDING; MUSCLE TWITCH; NONHUMAN; RECEPTOR AFFINITY;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; MICE; MOLECULAR STRUCTURE; MOTOR ACTIVITY; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; VAS DEFERENS;

EID: 0030725088     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9702950     Document Type: Article

References (49)

1. Devane, W. A.; Hanus, L.; Breuer, A.; Pertwee, R. G.; Stevenson, L. A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor. Science 1992, 258, 1946-1949.
2. Vogel, Z.; Barg, J.; Levy, R.; Saya, D.; Heldman, E.; Mechoulam, R. Anandamide, a Brain Endogenous Compound, Interacts Specifically with Cannabinoid Receptors and Inhibits Adenylate Cyclase. J. Neurochem. 1993, 61, 352-355.
3. Felder, C. C.; Briley, E. M.; Axelrod, J.; Simon, J. T.; Mackie, K.; Devane, W.A. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 7656-7660.
4. Childers, S. R.; Sexton, T.; Roy, M. B. Effects of Anandamide on Cannabinoid Receptors in Rat Brain Membranes. Biochem. Pharmacol. 1994, 47, 711-715.
5. Mackie, K.; Devane, W. A.; Hille, B. Anandamide, an Endogenous Cannabinoid, Inhibits Calcium Currents as a Partial Agonist in N18 Neuroblastoma Cells. Mol. Pharmacol. 1993, 44, 498-503.
6. Fride, E.; Mechoulam, R. Pharmacological Activity of the Cannabinoid Receptor Antagonist, Anandamide, a Brain Constituent. Eur. J. Pharmacol. 1993, 231, 313-314.
7. Crawley, J. N.; Corwin, R. L.; Robinson, J. K.; Felder, C. C.; Devane, W. A.; Axelrod, J. Anandamide, an Endogenous Ligand of the Cannabinoid Receptor, Induces Hypomotility and Hypothermia In Vivo in Rodents. Pharmacol. Biochem. Behav. 1993, 46, 967-972.
8. Smith, P. B.; Compton, D. R.; Welch, S. P.; Razdan, R. K.; Mechoulam, R.; Martin, B. R. The Pharmacological Activity of Anandamide, a Putative Endogenous Cannabinoid, in Mice. J. Pharmacol. Exp. Ther. 1994, 270, 219-227.
9. Pertwee, R. G.; Stevenson, L. A.; Griffin, G. Cross-tolerance between Delta-9-tetrahydrocannabinol and the Cannabimimetic Agents CP 55,940, Win 55,212-2 and Anandamide. Br. J. Pharmacol. 1993, 110, 1483-1490.
10. Corey, E. J.; Niwa, H.; Falck, J. R. Selective Epoxidation of Eicosa-cis-5,8,11,14-tetraenoic (Arachidonic) Acid and Eicosacis-8,11,14-trienoic Acid. J. Am. Chem. Soc. 1979, 101, 1586-1587.
11. Corey, E. J.; Iguchi, S.; Albright, J. O.; De, B. Studies on the Conformational Mobility of Arachidonic Acid. Facile Macrolactonization of 20-Hydroxyarachidonic Acid. Tetrahedron Lett. 1983, 24, 37-40.
12. Rich, M. R. Conformational Analysis of Arachidonic and Related Fatty Acids Using Molecular Dynamics Simulations. Biochim. Biophys. Acta 1993, 1178, 87-96.
13. Thomas, B. F.; Adams, I. B.; Mascarella, S. W.; Martin, B. R.; Razdan, R. K. Structure-Activity Analysis of Anandamide Analogs: Relationship to a Cannabinoid Pharmacophore. J. Med. Chem. 1996, 39, 471-479.
14. Devane, W. A.; Breuer, A.; Sheskin, T.; Jarbe, T. U. C.; Eisen, M. S.; Mechoulam, R. A novel probe for the cannabinoid receptor. J. Med. Chem. 1992, 35, 2065-2069.
15. 8-THC: A Novel, High Affinity Cannabinoid Receptor in the Brain. J. Med. Chem. 1994, 37, 3867-3870.
16. Tius, M. A.; Hill, W. A. G.; Zou, X. L.; Busch-Petersen, J.; Kawakami, J. K.; Fernandez-Garcia, M. C.; Drake, D. J.; Abadji, V.; Makriyannis, A. Classical/non-classical cannabinoid hybrids. Life Sci. 1995, 56, 2007-2012.
17. Huffman, J. W.; Yu, S.; Showalter, V.; Abood, M. E.; Wiley, J. W.; Compton, D.R.; Martin, B. R.; Bramblett, R. D.; Reggio, P. H. Synthesis and Pharmacology of a Very Potent Cannabinoid Lacking a Phenolic Hydroxyl with High Affinity for the CB2 Receptor. J. Med. Chem. 1996, 39, 3875-3877.
18. Martin, B. R.; Compton, D. R.; Prescott, W. R.; Barrett, R. L.; Razdan, R. K. Pharmacological evaluation of dimethylheptyl analogs of Delta 9-THC: Reassessment of the Putative three-point cannabinoid-receptor interaction. Drug Alcohol Depend. 1995, 37, 231-240.
19. Devane, W. A.; Dysarz, F. A.; Johnson, M. R.; Melvin, L. S.; Hewlett, A. C. Determination and Characterization of a Cannabinoid Receptor in Rat Brain. Mol. Pharmacol. 1988, 34, 605-613.
20. Matsuda, L. A.; Lolait, S. J.; Brownstein, M. J.; Young, A. C.; Bonner, T. I. Structure of a Cannabinoid Receptor and Functional Expression of the Cloned cDNA. Nature (London) 1990, 346, 561-564.
21. Munro, S.; Thomas, K. L.; Abu-Shaar, M. Molecular Characterization of a peripheral Receptor for Cannabinoids. Nature (London) 1993, 365, 61-65.
22. 9-THC-induced antinociception. J. Pharmacol. Exp. Ther. 1995, 273, 1235-1244.
23. Wise, M. L.; Soderstrom, K.; Murray, T. F.; Gerwick, W. H. Synthesis and cannabinoid receptor binding activity of conjugated triene anandamide, a novel eicosanoid. Experientia 1996, 52, 88-92.
24. Pinto, J. C.; Potie, F.; Rice, K. C.; Boring, D.; Johnson, M. R.; Evans, D. M.; Wilken, G. H.; Cantrell, C. H.; Hewlett, A. C. Cannabinoid Receptor Binding and Agonist Activity of Amides and Esters of Acachidonic Acid. Mol. Pharmacol. 1994, 46, 516-522.
25. Adams, I. B.; Ryan, W.; Singer, M.; Thomas, B. F.; Compton, D. R.; Razdan, R. K.; Martin, B. R. Evaluation of Cannabinoid Receptor Binding and In Vivo Activities for Anandamide Analogs. J. Pharmacol. Exp. Ther. 1995, 273, 1172-1181.
26. Adams, I. B.; Ryan, W.; Singer, M.; Razdan, R. K.; Compton, D. R.; Martin, B. R. Pharmacological and behavioral evaluation of alkylated anandamide analogs. Life Sci. 1995, 56, 2041-2048.
27. Abadji, V.; Lin, S.; Taha, G.; Griffin, G.; Stevenson, L. A.; Pertwee, R. G.; Makriyannis, A. (R)-Methandamide: A Chiral Novel Anandamide Possessing Higher Potency and Metabolic Stability. J. Med. Chem. 1994, 37, 1889-1893.
28. Khanolkar, A. D.; Abadji, V.; Lin, S.; Hill, W. A. G.; Taha, G.; Abouzid, K.; Meng, Z.; Fan, P.; Makriyannis, A. Head Group Analogs of Arachidonylethanolamide, the Endogenous Cannabinoid Ligand. J. Med. Chem. 1996, 39, 4515-4519.
29. Seltzman, H. H.; Fleming, D. N.; Gilliam, A. F.; Thomas, B. F. Synthesis and Receptor Binding of Dimethylheptylanandamide and Analogs. Presented at the 1996 Symposium on Cannabis and the Cannabinoids, West Dennis, MA, June 14-16, 1996.
30. Ryan, W.; Wyler, J.; Compton, D. R.; Martin, B. R.; Razdan, R. K. Novel Branched Chain Alkylanandamide Analogs. Presented at the 1996 Symposium on Cannabis and the Cannabinoids, West Dennis, MA, June 14-16,1996.
31. Experimental details and compound characterizations leading to aldehyde 6, including those for the modified epoxidation method, are provided in the experimental section since they had not been provided previously in the literature.
32. Manna, S.; Falck, J. R. Synthesis of Arachidonic Acid Metabolites Produced by Purified Kidney Cortex Microsomal Cytochrome P-450. Tetrahedron Lett. 1983, 24, 33-36.
33. Staab, H. A. Synthesis Using Heterocyclic Amides (Azolides). Angew. Chem. Int. Ed. Engl. 1962, 1, 351-367.
34. Staab, H. A.; Rohr, W.; Graf, F. Preparation of Diacyl Peroxides and Peresters According to the Imidazolide Method. Chem. Ber. 1965, 98, 1122-1124.
35. Seyferth, D.; Singh, G. Studies in Phosphinemethylene Chemistry. XII. Triphenylphosphine-t-butylmethylene and Triphenylphosphinetrimethylsilylmethylene. J. Am. Chem. Soc. 1965, 87, 4156-4162.
36. Carey, F. A.; Sundberg, R. J. Advanced Organic Chemistry, 3rd ed.; Plenum Press: New York and London, 1990; pp 98.
37. Vedejs, E.; Peterson, M. J. Stereochemistry and Mechanism in the Wittig Reaction. Top. Stereochem. 1994, 21, 1-157.
38. Hogberg, T.; Strom, P.; Ebner, M.; Ramsby, S. Cyanide as a Mild and Efficient Catalyst in the Aminolysis of Esters. J. Org. Chem. 1987, 52, 2033-2036.
39. Deutsch, D. G.; Chin, S. A. Enzymatic Synthesis and Degradation of Anandamide, A Cannabinoid Receptor Agonist. Biochem. Pharmacol. 1993, 46, 791-796.
40. Rinaldi-Carmona, M.; Barth, F.; Heaulme, M.; Shire, D.; Calandra, B.; Congy, C.; Martinez, S.; Maruani, J.; Neliat, G.; Caput, D.; Ferrara, P.; Soubrie, P.; Breliere, J.-C.; Le Fur, G. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 1994, 350, 240-244.
41. Seltzman, H. H.; Carroll, F. I.; Burgess, J. P.; Wyrick, C. D.; Burch, D. F. Synthesis, Spectral Studies and Tritiation of the Cannabinoid Antagonist SR141716A. J. Chem. Soc., Chem. Commun. 1995, 1549-1550.
42. Pertwee, R. G.; Stevenson, L. A.; Elrick, D. B.; Mechoulam, R.; Corbett, A. D. Inhibitory Effects of Certain Enantiomeric Cannabinoids in the Mouse Vas Deferens and the Myenteric Plexus Preparation of Guinea-pig Small Intestine. Br. J. Pharmacol. 1992, 105, 980-984.
43. Pertwee, R. G.; Griffin, G.; Lainton, J. A. H.; Huffman, J. W. Pharmacological Characterization of three Novel Cannabinoid Receptor Agonists in the Mouse Isolated Vas Deferens. Eur. J. Pharmacol. 1995, 284, 241-247.
44. Pertwee, R. G.; Fernando, S. R.; Griffin, G.; Abadji, V.; Makriyannis, A. Effect of Phenylmethylsulfonyl Fluoride on the Potency of Anandamide as an Inhibitor of Electrically-evoked Contractions in Two Isolated Tissue Preparations. Eur. J. Pharmacol. 1995, 272, 73-78.
45. Little, P. J.; Compton, D. R.; Johnson, M. R.; Melvin, L. S.; Martin, B. R. Pharmacology and Stereoselectivity of Structurally Novel Cannabinoids in Mice. J. Pharmacol. Exp. Ther. 1988, 247, 1046-1051.
46. Skaper, S. D.; Buriani, A.; Dal Toso, R.; Petrelli, L.; Romanello, S.; Facci, L.; Leon, A. The ALIAmide Palmitoylethanolamide and Cannabinoids, but not Anandamide, are Protective in a Delayed Postglutamate Paradigm of Excitotoxic Death in Cerebellar Granule Neurons. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 3984-3989.
47. Griffin, G.; Lainton, J. A. H.; Huffman, J. W.; Pertwee, R. Pharmacological Characterization of Four Novel Cannabinoid Receptor Agonists in the Mouse Vas Deferens. Presented at the 1996 Symposium on Cannabis and the Cannabinoids, West Dennis, MA.
48. Dewey, W. L.; Harris, L. S.; Howes, J. F.; Nuite, J. A. The Effect of Various Neurohumoral Modulators on the Activity of Morphine and the Narcotic Antagonists in the Tail-Flick and Phenylquinone Tests. J. Pharmacol. Exp. Ther. 1970, 175, 435-442.
49. Pertwee, R. G. The Ring Test: A Quantitative Method for Assessing the 'Cataleptic' Effect of Cannabis in Mice. Br. J. Pharmacol. 1972, 46, 753-763.